Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
An Open-Label, Multicenter Phase IB Study of the Safety and Efficacy of Atezolizu-L1 Antibody) Administered in Combination with Bevacizumab and/or Other Treatments in Patients with Solid Tumors (G030140) – Arm F Only
Dev, Anouk
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
16/11/18
→
15/11/22
View all
View less